Invesaro

Stocks ORKA Earnings

Earnings

Oruka Therapeutics, Inc. (ORKA) earnings

Quarterly results of Oruka Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when ORKA files with the SEC.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended September 30, 2026) Oruka Therapeutics, Inc. reported revenue of - and a net loss of $50M.

Filed with the SEC on November 9, 2026.

Net income by quarter
Q3 24: -$28.6M -$28.6M Q3 24Q1 25: -$21M -$21M Q1 25Q2 25: -$24.6M -$24.6M Q2 25Q3 25: -$30.3M -$30.3M Q3 25Q4 25: -$29.6M -$29.6M Q4 25Q1 26: -$31.8M -$31.8M Q1 26Q2 26: -$41.2M -$41.2M Q2 26Q3 26: -$50M -$50M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026September 30, 2026---$50M-
Q2 FY2026June 30, 2026---$41.2M-
Q1 FY2026March 31, 2026---$31.8M-
Q4 FY2025December 31, 2025---$29.6M-
Q3 FY2025September 30, 2025---$30.3M-
Q2 FY2025June 30, 2025---$24.6M-$0.46
Q1 FY2025March 31, 2025---$21M-$0.40
Q3 FY2024September 30, 2024---$28.6M-$1.46

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

Get an email when ORKA reports

Follow ORKA and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when ORKA files with the SEC.

Source: quarterly figures Oruka Therapeutics, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Oruka Therapeutics, Inc.